Cargando…

Repurposing Drugs for Inhibition against ALDH2 via a 2D/3D Ligand-Based Similarity Search and Molecular Simulation

Aldehyde dehydrogenase-2 (ALDH2) is a crucial enzyme participating in intracellular aldehyde metabolism and is acknowledged as a potential therapeutic target for the treatment of alcohol use disorder and other addictive behaviors. Using previously reported ALDH2 inhibitors of Daidzin, CVT-10216, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Wanyun, Chen, Junzhao, Zhang, Puyu, Zheng, Nannan, Ma, Le, Zhang, Yongguang, Zhang, Haiyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650273/
https://www.ncbi.nlm.nih.gov/pubmed/37959744
http://dx.doi.org/10.3390/molecules28217325
_version_ 1785135743219269632
author Jiang, Wanyun
Chen, Junzhao
Zhang, Puyu
Zheng, Nannan
Ma, Le
Zhang, Yongguang
Zhang, Haiyang
author_facet Jiang, Wanyun
Chen, Junzhao
Zhang, Puyu
Zheng, Nannan
Ma, Le
Zhang, Yongguang
Zhang, Haiyang
author_sort Jiang, Wanyun
collection PubMed
description Aldehyde dehydrogenase-2 (ALDH2) is a crucial enzyme participating in intracellular aldehyde metabolism and is acknowledged as a potential therapeutic target for the treatment of alcohol use disorder and other addictive behaviors. Using previously reported ALDH2 inhibitors of Daidzin, CVT-10216, and CHEMBL114083 as reference molecules, here we perform a ligand-based virtual screening of world-approved drugs via 2D/3D similarity search methods, followed by the assessments of molecular docking, toxicity prediction, molecular simulation, and the molecular mechanics Poisson–Boltzmann surface area (MM–PBSA) analysis. The 2D molecular fingerprinting of ECFP4 and FCFP4 and 3D molecule-shape-based USRCAT methods show good performances in selecting compounds with a strong binding behavior with ALDH2. Three compounds of Zeaxanthin (q = 0), Troglitazone (q = 0), and Sequinavir (q = +1 e) are singled out as potential inhibitors; Zeaxanthin can only be hit via USRCAT. These drugs displayed a stronger binding strength compared to the reported potent inhibitor CVT-10216. Sarizotan (q = +1 e) and Netarsudil (q = 0/+1 e) displayed a strong binding strength with ALDH2 as well, whereas they displayed a shallow penetration into the substrate-binding tunnel of ALDH2 and could not fully occupy it. This likely left a space for substrate binding, and thus they were not ideal inhibitors. The MM–PBSA results indicate that the selected negatively charged compounds from the similarity search and Vina scoring are thermodynamically unfavorable, mainly due to electrostatic repulsion with the receptor (q = −6 e for ALDH2). The electrostatic attraction with positively charged compounds, however, yielded very strong binding results with ALDH2. These findings reveal a deficiency in the modeling of electrostatic interactions (in particular, between charged moieties) in the virtual screening via the 2D/3D similarity search and molecular docking with the Vina scoring system.
format Online
Article
Text
id pubmed-10650273
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106502732023-10-29 Repurposing Drugs for Inhibition against ALDH2 via a 2D/3D Ligand-Based Similarity Search and Molecular Simulation Jiang, Wanyun Chen, Junzhao Zhang, Puyu Zheng, Nannan Ma, Le Zhang, Yongguang Zhang, Haiyang Molecules Article Aldehyde dehydrogenase-2 (ALDH2) is a crucial enzyme participating in intracellular aldehyde metabolism and is acknowledged as a potential therapeutic target for the treatment of alcohol use disorder and other addictive behaviors. Using previously reported ALDH2 inhibitors of Daidzin, CVT-10216, and CHEMBL114083 as reference molecules, here we perform a ligand-based virtual screening of world-approved drugs via 2D/3D similarity search methods, followed by the assessments of molecular docking, toxicity prediction, molecular simulation, and the molecular mechanics Poisson–Boltzmann surface area (MM–PBSA) analysis. The 2D molecular fingerprinting of ECFP4 and FCFP4 and 3D molecule-shape-based USRCAT methods show good performances in selecting compounds with a strong binding behavior with ALDH2. Three compounds of Zeaxanthin (q = 0), Troglitazone (q = 0), and Sequinavir (q = +1 e) are singled out as potential inhibitors; Zeaxanthin can only be hit via USRCAT. These drugs displayed a stronger binding strength compared to the reported potent inhibitor CVT-10216. Sarizotan (q = +1 e) and Netarsudil (q = 0/+1 e) displayed a strong binding strength with ALDH2 as well, whereas they displayed a shallow penetration into the substrate-binding tunnel of ALDH2 and could not fully occupy it. This likely left a space for substrate binding, and thus they were not ideal inhibitors. The MM–PBSA results indicate that the selected negatively charged compounds from the similarity search and Vina scoring are thermodynamically unfavorable, mainly due to electrostatic repulsion with the receptor (q = −6 e for ALDH2). The electrostatic attraction with positively charged compounds, however, yielded very strong binding results with ALDH2. These findings reveal a deficiency in the modeling of electrostatic interactions (in particular, between charged moieties) in the virtual screening via the 2D/3D similarity search and molecular docking with the Vina scoring system. MDPI 2023-10-29 /pmc/articles/PMC10650273/ /pubmed/37959744 http://dx.doi.org/10.3390/molecules28217325 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Jiang, Wanyun
Chen, Junzhao
Zhang, Puyu
Zheng, Nannan
Ma, Le
Zhang, Yongguang
Zhang, Haiyang
Repurposing Drugs for Inhibition against ALDH2 via a 2D/3D Ligand-Based Similarity Search and Molecular Simulation
title Repurposing Drugs for Inhibition against ALDH2 via a 2D/3D Ligand-Based Similarity Search and Molecular Simulation
title_full Repurposing Drugs for Inhibition against ALDH2 via a 2D/3D Ligand-Based Similarity Search and Molecular Simulation
title_fullStr Repurposing Drugs for Inhibition against ALDH2 via a 2D/3D Ligand-Based Similarity Search and Molecular Simulation
title_full_unstemmed Repurposing Drugs for Inhibition against ALDH2 via a 2D/3D Ligand-Based Similarity Search and Molecular Simulation
title_short Repurposing Drugs for Inhibition against ALDH2 via a 2D/3D Ligand-Based Similarity Search and Molecular Simulation
title_sort repurposing drugs for inhibition against aldh2 via a 2d/3d ligand-based similarity search and molecular simulation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650273/
https://www.ncbi.nlm.nih.gov/pubmed/37959744
http://dx.doi.org/10.3390/molecules28217325
work_keys_str_mv AT jiangwanyun repurposingdrugsforinhibitionagainstaldh2viaa2d3dligandbasedsimilaritysearchandmolecularsimulation
AT chenjunzhao repurposingdrugsforinhibitionagainstaldh2viaa2d3dligandbasedsimilaritysearchandmolecularsimulation
AT zhangpuyu repurposingdrugsforinhibitionagainstaldh2viaa2d3dligandbasedsimilaritysearchandmolecularsimulation
AT zhengnannan repurposingdrugsforinhibitionagainstaldh2viaa2d3dligandbasedsimilaritysearchandmolecularsimulation
AT male repurposingdrugsforinhibitionagainstaldh2viaa2d3dligandbasedsimilaritysearchandmolecularsimulation
AT zhangyongguang repurposingdrugsforinhibitionagainstaldh2viaa2d3dligandbasedsimilaritysearchandmolecularsimulation
AT zhanghaiyang repurposingdrugsforinhibitionagainstaldh2viaa2d3dligandbasedsimilaritysearchandmolecularsimulation